Global, regional, and national burden of 34 cancer groups across 204 countries and territories, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
Despite advances in detection and treatment, the rising global cancer burden and persistent disparities highlight the urgent need for equitable prevention, early diagnosis, and resource allocation to reduce cancer mortality worldwide. The potential long-term impact of COVID-19 on cancer development and progression remains unclear, warranting further investigation in the post-pandemic era.
Authors
- Xiaotong Sun (ORCID: https://orcid.org/0000-0001-5628-0994)
- Sheng Ding (ORCID: https://orcid.org/0000-0002-3354-1263)
- Jiangpeng Zhu (ORCID: https://orcid.org/0000-0002-3687-6472)
- Jiafeng Zhao
- Yuwei Yuan (ORCID: https://orcid.org/0000-0001-6707-2373)
- Li‐Hua Zhu (ORCID: https://orcid.org/0000-0002-9325-3845)
- Shuangshuang Hou
- Qingsong Wang (ORCID: https://orcid.org/0000-0002-6686-195X)
- Lei Liu (ORCID: https://orcid.org/0000-0002-6490-5568)
Institutions
- Fuyang Normal University (CN)
- Wenzhou Medical University (CN)
- Wuhu Fourth People Hospital (CN)
- Obstetrics and Gynecology Hospital of Fudan University (CN)
- Central Hospital of Zibo (CN)
- Zhejiang Taizhou Hospital (CN)
- Fuyang Second People's Hospital (CN)
- Anhui Normal University (CN)
- Anhui University of Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.3389/fonc.2025.1660125
- Citations
- 4
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 4.18